|

Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

RECRUITINGSponsored by Endeavor Health
Actively Recruiting
SponsorEndeavor Health
Started2021-12-13
Est. completion2026-12-13
Eligibility
Age40 Years – 69 Years
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05295407

Summary

Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment

Eligibility

Age: 40 Years – 69 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Consecutive patients undergoing prostate biopsy for detection of prostate cancer
* Aged 40 to 69 years
* Four ethnicity groups (Caucasian, African Americans, East Asians, Latinos)
* PSA between 2.5-10 ng/mL

Exclusion Criteria:

* Previous diagnosis of prostate cancer.
* Ethnicity outside the inclusion criterion (including mixed ethnicity).
* Any prior PSA test result outside the range of inclusion criterion.

Conditions2

CancerProstate Cancer

Locations1 site

NorthShore University HealthSystem
Evanston, Illinois, 60626
Pooja Talaty847-503-4280ptalaty@northshore.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.